NCI Director Ned Sharpless to become acting FDA commissioner

Share

NCI Director Ned Sharpless will become the interim leader of the FDA in early April once Scott Gottlieb’s resignation becomes effective, says HHS Secretary Alex Azar.

A search for a permanent FDA Commissioner is ongoing. Sharpless has served as head of the NCI since October 2017. Prior to that, he was director of the University of North Carolina Lineberger Comprehensive Cancer Center.

Read the full article at biopharmadive.com…

Share

Comments are closed.

Read previous post:
Top 10 drugs losing exclusivity in 2019

Pharma companies do their best to fight patent expirations and generic competition to protect their top-selling drugs, but 2019 looks...

Close